Federal Supply Schedule V797D70134
Award Date
4/15/17
Last Date to Order
8/31/26
Federal Agency
Veterans Integrated Service Network 12
Awardee
Alvogen, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) awarded a $505.3 million single-award Indefinite Delivery Contract (IDC) to Alvogen, Inc. to deliver the antiviral drug oseltamivir phosphate to the Strategic National Stockpile. This IDC, which has an ultimate completion date of February 6, 2025, allows ASPR to issue task orders to Alvogen for the procurement and distribution of this essential medical countermeasure to...
This federal contract indefinite delivery vehicle (IDV) is a $4.9 billion Federal Supply Schedule (FSS) awarded by the Department of Veterans Affairs (VA) to the prime contractor Genentech USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract covers a wide range of drugs, pharmaceuticals, and hematology-related products under the FSS-61-IB schedule. The IDV has facilitated several delivery orders, including a $45.1 million firm fixed-price contract with the Office of...
The federal contract IDV award is a multiple-award Federal Supply Schedule (FSS) contract with the Department of Veterans Affairs (VA) for pharmaceutical and related medical products under Schedule 65 IB. The prime contractor is Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract has a $3.6 billion ceiling value and a period of performance from August 15, 2017 to August 31, 2025. Under this IDV, Teva has received a $658,441.16 firm-fixed-price...
The provided information describes an Indefinite Delivery Contract (IDC) awarded by the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to Roche Laboratories Inc. The IDC, with a ceiling value of $131,245,722.23, is for the acquisition of the antiviral drug Tamiflu to support a public health emergency response to a pandemic. The contract was awarded on June 29, 2006, with a period of performance through September 1, 2010. This...
The federal contract IDV is a multiple-award Federal Supply Schedule contract with the Department of Veterans Affairs (VA) for the procurement of pharmaceutical products, medical supplies, and vaccines. The contract has a total ceiling value of $3.9 billion and a period of performance through July 31, 2027. The prime contractor is Glaxosmithkline, LLC, a foreign-owned, for-profit pharmaceutical company that provides a range of medical products to various federal agencies. Under this IDV,...
This indefinite delivery contract was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The contract has a ceiling value of $10,164,262.95 and a period of performance from February 22, 2024 to February 21, 2026. The purpose of this contract is to procure oseltamivir phosphate capsules and suspension for distribution to the VA, Department of Defense...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, awarded by the Veterans Integrated Service Network 12 (VISN 12) of the U.S. Department of Veterans Affairs (VA). The prime contractor is Amphastar Pharmaceuticals, Inc., a for-profit manufacturer of pharmaceutical goods. The $58,244,500 multiple award contract has a period of performance through January 14, 2027 and aims to procure a broad range of drug,...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) to AstraZeneca Pharmaceuticals LP, a foreign-owned, for-profit pharmaceutical manufacturer. The contract, valued at up to $11.7 billion, covers the provision of drugs, pharmaceuticals, and hematology-related products (FSS Contract 65 I B) to federal agencies. Under this multiple-award IDV, AstraZeneca has been issued a $43,631 firm-fixed-price delivery order by the...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government. The contract was awarded to Amarin Pharma, Inc., a for-profit organization, with a period of performance from September 1, 2024 to August 31, 2029. The contract has a ceiling value of $1,844,760.00 and covers the procurement of drugs, pharmaceuticals, and hematology-related products under the FSS contract...
The federal contract IDV award summarized is a Federal Supply Schedule (FSS) contract with a maximum ceiling value of $5,914,559,260.00. The contracting agency is the Department of Veterans Affairs (VA) through the VA National Acquisition Center. The prime contractor is Golden State Medical Supply, Inc., a for-profit pharmaceutical manufacturer and distributor based in Camarillo, California. The contract covers a wide range of essential pharmaceutical products, predominantly focused on the...
Name | Description | Awardee | Potential Value (Click to sort descending) | Award Date (Click to sort descending) | Completion Date (Click to sort descending) | Updated At (Click to sort descending) |
|---|---|---|---|---|---|---|
Delivery Order V797D70134-75A50325F80013 | Alvogen, Inc. | $227.7m | 6/30/25 | 6/29/27 | 7/2/25 |